Table 1.

Rescue of MTAP+ primary T-ALL from L-alanosine toxicity



MTAP exon 8*

MTAP RNA*

MTAP protein

3H-thymidine incorporation, % of control
Patient
Without EFA
With EFA
Normal PBMCs   ND   +   +   37.8 ± 2.3   101 ± 4.0  
061219   +   +   +   51.7 ± 1.7   82.2 ± 2.2  
220112   +   +   +   58.1 ± 4.0   99.9 ± 10.4  
130312   +   +   +   57.1 ± 7.1   89.4 ± 4.6  
131518-R   +   ND   ND   72.6 ± 2.6   92.5 ± 8.1  
190114   –   –   –   3.4 ± 0.8   5.1 ± 1.0  
122614-R   +   +   –   12.9 ± 1.3   37.6 ± 2.6  
260512
 
+
 
+
 
ND
 
14.4 ± 0.9
 
24.1 ± 0.8
 


MTAP exon 8*

MTAP RNA*

MTAP protein

3H-thymidine incorporation, % of control
Patient
Without EFA
With EFA
Normal PBMCs   ND   +   +   37.8 ± 2.3   101 ± 4.0  
061219   +   +   +   51.7 ± 1.7   82.2 ± 2.2  
220112   +   +   +   58.1 ± 4.0   99.9 ± 10.4  
130312   +   +   +   57.1 ± 7.1   89.4 ± 4.6  
131518-R   +   ND   ND   72.6 ± 2.6   92.5 ± 8.1  
190114   –   –   –   3.4 ± 0.8   5.1 ± 1.0  
122614-R   +   +   –   12.9 ± 1.3   37.6 ± 2.6  
260512
 
+
 
+
 
ND
 
14.4 ± 0.9
 
24.1 ± 0.8
 

Primary T-All cells were plated at 0.5 × 106 cells/mL and cultured for 3 days in complete RPMI alone (control) or in complete RPMI containing 40 μM L-alanosine and increasing concentrations of EFA up to 40 μM. Cells were then pulsed with 3H-thymidine for 6 hours and incorporation of 3H-thymidine was determined in a scintillation counter. All culture conditions were performed in triplicate and error bars represent standard deviation. Patients 190114, 122614-R, and 260512 had MTAP-deficient and the other patients had MTAP-abundant cells. MTAP status is based on MTAP protein expression and activity as demonstrated by rescue from L-alanosine toxicity by EFA.

ND indicates not determined

*

Determined by PCR

Close Modal

or Create an Account

Close Modal
Close Modal